Search
for
Sort by
Research 451–480 of 579
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
- Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Alopecia Areata: Current Treatments and New Directions
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Frontiers in alopecia areata pathobiology research
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- New and Emerging Therapies for Alopecia Areata
- Pathomechanisms of immune-mediated alopecia
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Immunology of alopecia areata
- Parsing patterns: Emerging roles of tissue self-organization in health and disease
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
- Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata
- Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathways
- Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure
- Regenerative Medicine-Based Treatment for Vitiligo: An Overview
- Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- A “hair‐raising” history of alopecia areata
- Understanding the Role of Type I Interferons in Cutaneous Lupus and Dermatomyositis: Toward Better Therapeutics